Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20 participants
OBSERVATIONAL
2024-10-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EMG to Detect and Monitor Freezing of Gait Among People With Parkinson's Disease
NCT05693207
Investigating Therapies for Freezing of Gait
NCT03065127
Brain-Machine Interface for Freezing of Gait
NCT06642519
Investigating the Neural Signature of Freezing of Gait in Parkinson's Disease
NCT06841718
Understanding Freezing of Gait Using Brain Signals and Virtual Reality
NCT07092995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Freezing Of Gait Patients
15 patients with Parkinson disease with freezing of gait (group) in ON \& OFF states
Opals
Five Oplas sensors were strategically placed on participants: one on each shin, one on each foot, and one on the lower back.
Axivity
At the end of the first session, participants with FOG, will be fitted with an Axivity monitor. This is wearable sensor that will be attached to the participant's lower back (lumbar vertebrae 4-5) with hypoallergic medical tape by the researcher, and will be worn continuously for seven days.
The Axivity monitor is a small (23 x 32.5 x 8.9 mm) and lightweight (11g) device that measures mobility via a tri-axial accelerometer and gyroscope and stores this data onboard, no GPS or other localization options are possible with this monitor. Participants will be given following guidelines concerning the use:
The sensor is to be worn continuously during the seven-day period, i.e. also while sleeping and showering.
The sensor is waterproof and can be worn during showering.
Non Freezing Of Gait Patients
5 patients with Parkinson disease without freezing of gait (cohort) in ON \& OFF states
Opals
Five Oplas sensors were strategically placed on participants: one on each shin, one on each foot, and one on the lower back.
Axivity
At the end of the first session, participants with FOG, will be fitted with an Axivity monitor. This is wearable sensor that will be attached to the participant's lower back (lumbar vertebrae 4-5) with hypoallergic medical tape by the researcher, and will be worn continuously for seven days.
The Axivity monitor is a small (23 x 32.5 x 8.9 mm) and lightweight (11g) device that measures mobility via a tri-axial accelerometer and gyroscope and stores this data onboard, no GPS or other localization options are possible with this monitor. Participants will be given following guidelines concerning the use:
The sensor is to be worn continuously during the seven-day period, i.e. also while sleeping and showering.
The sensor is waterproof and can be worn during showering.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Opals
Five Oplas sensors were strategically placed on participants: one on each shin, one on each foot, and one on the lower back.
Axivity
At the end of the first session, participants with FOG, will be fitted with an Axivity monitor. This is wearable sensor that will be attached to the participant's lower back (lumbar vertebrae 4-5) with hypoallergic medical tape by the researcher, and will be worn continuously for seven days.
The Axivity monitor is a small (23 x 32.5 x 8.9 mm) and lightweight (11g) device that measures mobility via a tri-axial accelerometer and gyroscope and stores this data onboard, no GPS or other localization options are possible with this monitor. Participants will be given following guidelines concerning the use:
The sensor is to be worn continuously during the seven-day period, i.e. also while sleeping and showering.
The sensor is waterproof and can be worn during showering.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Able to walk independently for a distance of 10 meters, without walking aid;
3. Absence of a Deep Brain Stimulator;
4. Stable PD treatment in the 4 weeks prior to participation that is not expected to change in the course of the study.
5. For patients with FOG: a score of ≥ 1 on the New Freezing Of Gait Questionnaire (NFOG-Q).
Exclusion Criteria
2. Unwilling to temporarily delay the morning anti-Parkinsonian medication.
3. Preganacy and
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Oregon Health and Science University
OTHER
University of Sydney
OTHER
Radbound University Medical Center
UNKNOWN
University of Waterloo
OTHER
Emory University
OTHER
University of Rochester
OTHER
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv Saurasky Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jeffery Hausdorff, Proffesor
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0608-23-TLV
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.